These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10651783)

  • 21. A field with a liver measles-mumps-rubella vaccine.
    Walters VW; Miller SA; Jackson JE; Kenny MT
    Clin Pediatr (Phila); 1975 Oct; 14(10):928-33. PubMed ID: 1100294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The measles-mumps-rubella vaccination program in Finland.
    Redd SC; Wharton M; Hadler SC; Orenstein WA
    N Engl J Med; 1995 Apr; 332(16):1102-3. PubMed ID: 7898540
    [No Abstract]   [Full Text] [Related]  

  • 23. [Experience with preventive measles, mumps and rubella vaccination in unified Germany].
    Gerike E; Tischer A
    Gesundheitswesen; 1993 Jan; 55(1):38-9. PubMed ID: 8435543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MMR vaccine--one year on.
    Walker D
    Practitioner; 1990 May; 234(1489):550-2. PubMed ID: 2392406
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical evaluation of a new measles-mumps-rubella combined live virus vaccine in the Dominican Republic.
    Ehrenkranz NJ; Ventura AK; Medler EM; Jackson JE; Kenny MT
    Bull World Health Organ; 1975; 52(1):81-5. PubMed ID: 764997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [1st results with a combined live vaccine against measles, mumps, and rubella].
    Stehr K; Epp C; Spiess H
    Monatsschr Kinderheilkd (1902); 1975 May; 123(5):410-2. PubMed ID: 1219453
    [No Abstract]   [Full Text] [Related]  

  • 27. A second dose of MMR vaccine for children in the United Kingdom.
    Commun Dis Rep CDR Wkly; 1996 Jul; 6(30):259. PubMed ID: 8755703
    [No Abstract]   [Full Text] [Related]  

  • 28. From the Centers for Disease Control and Prevention. Measles--United States, 1996, and the interruption of indigenous transmission.
    JAMA; 1997 May; 277(17):1345-6. PubMed ID: 9134928
    [No Abstract]   [Full Text] [Related]  

  • 29. Evaluation of live trivalent vaccine of measles AIK-C strain, mumps Hoshino strain and rubella Takahashi strain, by virus-specific interferon-gamma production and antibody response.
    Nakayama T; Urano T; Osano M; Nakagawa M; Maehara N; Sasaki K; Yamamura AM; Makino S
    Microbiol Immunol; 1990; 34(6):497-508. PubMed ID: 2120551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Administration of measles, mumps, and rubella virus vaccine (live) to egg-allergic children.
    Lavi S; Zimmerman B; Koren G; Gold R
    Crit Care Nurse; 1990 Apr; 10(4):80-2. PubMed ID: 2328615
    [No Abstract]   [Full Text] [Related]  

  • 31. Decreased measles antibody response after measles-mumps-rubella vaccine in infants with colds.
    Krober MS; Stracener CE; Bass JW
    JAMA; 1991 Apr; 265(16):2095-6. PubMed ID: 2013930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K; Nicoara C; Germann D; Matter L
    Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measles, mumps, rubella vaccine administration in egg-sensitive children: systemic reactions during vaccine desensitization.
    Trotter AC; Stone BD; Laszlo DJ; Georgitis JW
    Ann Allergy; 1994 Jan; 72(1):25-8. PubMed ID: 8291745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mumps vaccination.
    Hilleman MR
    Mod Trends Med Virol; 1970; 2(0):241-61. PubMed ID: 5527958
    [No Abstract]   [Full Text] [Related]  

  • 35. Antibody persistence after primary measles-mumps-rubella vaccine and response to a second dose given at four to six vs. eleven to thirteen years.
    Johnson CE; Kumar ML; Whitwell JK; Staehle BO; Rome LP; Dinakar C; Hurni W; Nalin DR
    Pediatr Infect Dis J; 1996 Aug; 15(8):687-92. PubMed ID: 8858673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes of the immunological patterns against measles, mumps and rubella. A vaccination programme studied 3 to 7 years after the introduction of a two-dose schedule.
    Christenson B; Böttiger M
    Vaccine; 1991 May; 9(5):326-9. PubMed ID: 1872016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measles vaccination: revised recommendations for immunization.
    Reece SM
    Nurse Pract; 1990 Dec; 15(12):19-20, 23-4. PubMed ID: 2284058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measles, mumps, and rubella vaccine: time for a two stage policy?
    Carter H; Gorman D
    BMJ; 1992 Mar; 304(6827):637. PubMed ID: 1559098
    [No Abstract]   [Full Text] [Related]  

  • 39. Providing MMR vaccine to children.
    Orenstein WA; Plotkin S
    Minn Med; 1991 Mar; 74(3):7-8. PubMed ID: 2030684
    [No Abstract]   [Full Text] [Related]  

  • 40. [Vaccination against measles, mumps and German measles. I. Medical and epidemiological aspects].
    Bjerregaard P; Pedersen KM; Kamper-Jørgensen F; Koch C; Pedersen FK; Wagner AL; Zoffmann H
    Ugeskr Laeger; 1985 Sep; 147(38):3013-7. PubMed ID: 4071749
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.